A Case of Duffy-Null-Associated Neutropenia in a Patient With Chronic Myeloid Leukemia. (PubMed, Case Rep Hematol) - Sep 28, 2026 - "Subsequently, she began treatment with imatinib (Gleevec) 400 mg daily...After several treatment changes due to adverse effects, she began treatment with asciminib 80 mg daily...Early detection of Duffy-null status can prevent dose reductions in therapy and delayed remission. Particularly with African American patients, a better framework for addressing Duffy-null neutropenia may benefit long-term outcomes in the setting of cancer therapy."
Journal • Chronic Myeloid Leukemia • Fatigue • Hematological Disorders • Hematological Malignancies • Infectious Disease • Leukemia • Neutropenia • Oncology • ABL1 • BCR
|
|
Anushka Parekh; Joanna Metzner-Sadurski
|